Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-14

Clinical Trial Update: A Study of SHR-1314 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of SHR-1314 in healthy subjects has completed; psoriasis is listed as the condition associated with the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR-1314 (SHR-1314)

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED